Global Breast Cancer Therapeutic Market Size, Status and Forecast 2025

June 2018 | 94 pages | ID: G79F6EFE5F9EN
QYResearch

Abstracts

This report studies the global Breast Cancer Therapeutic market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Breast Cancer Therapeutic market by companies, region, type and end-use industry.
In 2017, the global Breast Cancer Therapeutic market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

• AstraZeneca
• Eisai
• Eli Lilly and Company
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis International AG
• Pfizer
• Puma Biotechnology
• Sanofi S.A.
• Teva Pharmaceutical Industries

Market segment by Regions/Countries, this report covers

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

Market segment by Type, the product can be split into

• Phase I Treatment
• Phase II Treatment
• Phase III Treatment

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Center
• Diagnostic Centers

The study objectives of this report are:

• To study and forecast the market size of Breast Cancer Therapeutic in global market.
• To analyze the global key players, SWOT analysis, value and global market share for top players.
• To define, describe and forecast the market by type, end use and region.
• To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
• To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Breast Cancer Therapeutic are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Breast Cancer Therapeutic Manufacturers
Breast Cancer Therapeutic Distributors/Traders/Wholesalers
Breast Cancer Therapeutic Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Breast Cancer Therapeutic market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Breast Cancer Therapeutic Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF BREAST CANCER THERAPEUTIC

1.1 Breast Cancer Therapeutic Market Overview
  1.1.1 Breast Cancer Therapeutic Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Breast Cancer Therapeutic Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 Europe
  1.2.3 China
  1.2.4 Japan
  1.2.5 Southeast Asia
  1.2.6 India
1.3 Breast Cancer Therapeutic Market by Type
  1.3.1 Phase I Treatment
  1.3.2 Phase II Treatment
  1.3.3 Phase III Treatment
1.4 Breast Cancer Therapeutic Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Ambulatory Surgical Center
  1.4.3 Diagnostic Centers

2 GLOBAL BREAST CANCER THERAPEUTIC COMPETITION ANALYSIS BY PLAYERS

2.1 Breast Cancer Therapeutic Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 AstraZeneca
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.2 Eisai
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.3 Eli Lilly and Company
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.4 F. Hoffmann-La Roche
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.5 GlaxoSmithKline
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.6 Novartis International AG
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.7 Pfizer
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.8 Puma Biotechnology
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.9 Sanofi S.A.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)
3.10 Teva Pharmaceutical Industries
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Breast Cancer Therapeutic Revenue (Million USD) (2013-2018)

4 GLOBAL BREAST CANCER THERAPEUTIC MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Breast Cancer Therapeutic Market Size by Type (2013-2018)
4.2 Global Breast Cancer Therapeutic Market Size by Application (2013-2018)
4.3 Potential Application of Breast Cancer Therapeutic in Future
4.4 Top Consumer/End Users of Breast Cancer Therapeutic

5 UNITED STATES BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Breast Cancer Therapeutic Market Size (2013-2018)
5.2 United States Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
5.3 United States Breast Cancer Therapeutic Market Size by Application (2013-2018)

6 EUROPE BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

6.1 Europe Breast Cancer Therapeutic Market Size (2013-2018)
6.2 Europe Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
6.3 Europe Breast Cancer Therapeutic Market Size by Application (2013-2018)

7 CHINA BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

7.1 China Breast Cancer Therapeutic Market Size (2013-2018)
7.2 China Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
7.3 China Breast Cancer Therapeutic Market Size by Application (2013-2018)

8 JAPAN BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

8.1 Japan Breast Cancer Therapeutic Market Size (2013-2018)
8.2 Japan Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
8.3 Japan Breast Cancer Therapeutic Market Size by Application (2013-2018)

9 SOUTHEAST ASIA BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

9.1 Southeast Asia Breast Cancer Therapeutic Market Size (2013-2018)
9.2 Southeast Asia Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Breast Cancer Therapeutic Market Size by Application (2013-2018)

10 INDIA BREAST CANCER THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

10.1 India Breast Cancer Therapeutic Market Size (2013-2018)
10.2 India Breast Cancer Therapeutic Market Size and Market Share by Players (2013-2018)
10.3 India Breast Cancer Therapeutic Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Breast Cancer Therapeutic Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
  11.1.2 Europe Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
  11.1.3 China Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
  11.1.4 Japan Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
  11.1.5 Southeast Asia Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
  11.1.6 India Breast Cancer Therapeutic Revenue and Growth Rate (2018-2025)
11.2 Global Breast Cancer Therapeutic Market Size (Value) by Type (2018-2025)
11.3 Global Breast Cancer Therapeutic Market Size by Application (2018-2025)

12 BREAST CANCER THERAPEUTIC MARKET DYNAMICS

12.1 Breast Cancer Therapeutic Market Opportunities
12.2 Breast Cancer Therapeutic Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Breast Cancer Therapeutic Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Breast Cancer Therapeutic Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Breast Cancer Therapeutic Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Breast Cancer Therapeutic Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Breast Cancer Therapeutic Market Share by Regions (2013-2018)
Figure United States Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Breast Cancer Therapeutic Revenue Market Share by Type in 2017
Figure Phase I Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Figure Phase II Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Figure Phase III Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Breast Cancer Therapeutic Market Share by Application in 2017
Figure Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate in Ambulatory Surgical Center (2013-2018)
Figure Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate in Diagnostic Centers (2013-2018)
Table Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure Breast Cancer Therapeutic Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Eisai Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Eisai (2013-2018)
Figure Eisai Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Eli Lilly and Company (2013-2018)
Figure Eli Lilly and Company Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Novartis International AG Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Novartis International AG (2013-2018)
Figure Novartis International AG Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Puma Biotechnology Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Puma Biotechnology (2013-2018)
Figure Puma Biotechnology Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Sanofi S.A. Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Sanofi S.A. (2013-2018)
Figure Sanofi S.A. Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Industries Basic Information List
Table Breast Cancer Therapeutic Business Revenue (Million USD) of Teva Pharmaceutical Industries (2013-2018)
Figure Teva Pharmaceutical Industries Breast Cancer Therapeutic Business Revenue Market Share (2013-2018)
Table Global Breast Cancer Therapeutic Market Size (Million USD) by Product (2013-2018)
Figure Global Breast Cancer Therapeutic Revenue Market Share (%) by Product (2013-2018)
Figure Global Breast Cancer Therapeutic Market Share by Product in 2017
Table Global Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure Global Breast Cancer Therapeutic Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Breast Cancer Therapeutic
Figure United States Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure United States Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure United States Breast Cancer Therapeutic Market Size Share by Players in 2017
Table United States Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure United States Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure United States Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure Europe Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure Europe Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure Europe Breast Cancer Therapeutic Market Size Share by Players in 2017
Table Europe Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure Europe Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure Europe Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure China Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table China Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure China Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure China Breast Cancer Therapeutic Market Size Share by Players in 2017
Table China Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure China Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure China Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure Japan Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure Japan Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure Japan Breast Cancer Therapeutic Market Size Share by Players in 2017
Table Japan Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure Japan Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure Japan Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure Southeast Asia Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure Southeast Asia Breast Cancer Therapeutic Market Size Share by Players in 2017
Table Southeast Asia Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure Southeast Asia Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure India Breast Cancer Therapeutic Market Size (Million USD) and Growth Rate (2013-2018)
Table India Breast Cancer Therapeutic Market Size (Million USD) by Players (2013-2018)
Figure India Breast Cancer Therapeutic Market Size Share by Players in 2013
Figure India Breast Cancer Therapeutic Market Size Share by Players in 2017
Table India Breast Cancer Therapeutic Market Size by Application (2013-2018)
Figure India Breast Cancer Therapeutic Revenue Market Share (%) by Application (2013-2018)
Figure India Breast Cancer Therapeutic Market Size Share by Application in 2017
Figure Global Breast Cancer Therapeutic Market Size and Growth Rate (2018-2025)
Table Global Breast Cancer Therapeutic Market Size (Million USD) by Regions (2018-2025)
Figure Global Breast Cancer Therapeutic Market Size Share (2018-2025)
Figure Global Breast Cancer Therapeutic Market Size Share by Regions in 2025
Figure United States Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Breast Cancer Therapeutic Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Breast Cancer Therapeutic Market Size (Million USD) by Type (2018-2025)
Figure Global Breast Cancer Therapeutic Market Size Share by Type in 2018
Figure Global Breast Cancer Therapeutic Market Size Share by Type in 2025
Table Global Breast Cancer Therapeutic Market Size (Million USD) by Application (2018-2025)
Figure Global Breast Cancer Therapeutic Market Size (Million USD) by Application in 2018